- Raw materials
- Antipsychotics
- Valpromide
Filters
Custom request?
Type
Production region
Qualifications
Country of origin
Valpromide API Manufacturers & Suppliers
1 verified results
All Valpromide data. Full access. Full negotiation power
Commercial-scale Suppliers
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Valpromide | GMP-certified suppliers
A medication that supports seizure control and central nervous system depression, primarily investigated as an anticonvulsant within fatty acid derivative classes for neurological therapeutic development.
Therapeutic categories
Product Snapshot
- Valpromide is an oral small molecule available in capsule and delayed-release tablet formulations
- It is primarily investigated for neurological and psychiatric therapeutic applications
- Valpromide currently holds experimental status with no formal approvals from major regulatory agencies
Clinical Overview
Valpromide has been investigated as an anticonvulsant and central nervous system depressant, placing it within pharmacological classes that include fatty acid derivatives and pentanoic acids. Its chemical profile situates it among volatile fatty acids and valerates, reflecting its structural and metabolic relationships to other fatty acid-based central nervous system agents.
Although currently classified as experimental and not widely approved for clinical use, valpromide's mechanism of action is inferred to be connected to modulation of neurotransmitter systems implicated in seizure control and CNS depression, consistent with the pharmacodynamics typical of related valproic acid compounds. It is presumed to influence neuronal excitability, although definitive pharmacological and clinical data remain limited.
Key absorption, distribution, metabolism, and excretion (ADME) parameters for valpromide are not comprehensively described in the public domain. However, as an organic acid derivative related to known anticonvulsants, it is likely metabolized hepatically, with potential conversion to active metabolites under enzymatic pathways analogous to those observed in valproic acid metabolism.
Safety and toxicity considerations are not fully established given its experimental status. Careful evaluation is required during any investigational use due to the potential for CNS depressant effects and the metabolic liabilities common to fatty acid derivatives with CNS activity.
Valpromide is not currently marketed under notable brand names and remains primarily of interest in research and formulation development contexts.
From a sourcing and quality perspective, procurement of valpromide active pharmaceutical ingredient (API) should prioritize suppliers that provide comprehensive analytical documentation, including purity profiles, residual solvent analysis, and validation of identity consistent with regulatory guidelines. Ensuring pharmaceutical-grade quality and compliance with current good manufacturing practices is essential for experimental and investigational use.
Identification & chemistry
| Generic name | Valpromide |
|---|---|
| Molecule type | Small molecule |
| UNII | RUA6CWU76G |
| DrugBank ID | DB04165 |
Pharmacology
Targets
| Target | Organism | Actions |
|---|---|---|
| Limonene-1,2-epoxide hydrolase | Rhodococcus erythropolis |
Formulation & handling
- Valpromide is formulated for oral administration primarily in capsule and delayed-release tablet forms.
- It is a small molecule with moderate water solubility, allowing standard powder handling precautions.
- Stability considerations should focus on maintaining solid-state integrity and protecting from moisture during storage.
Regulatory status
Valpromide is a type of Antipsychotics
Antipsychotics belong to the pharmaceutical API (Active Pharmaceutical Ingredient) category used to treat psychiatric disorders such as schizophrenia, bipolar disorder, and other related conditions. These medications play a crucial role in managing symptoms associated with psychosis, including hallucinations, delusions, and disorganized thinking.
Antipsychotics work by modulating the levels of neurotransmitters in the brain, particularly dopamine and serotonin. They can be categorized into two classes: first-generation (typical) antipsychotics and second-generation (atypical) antipsychotics. Typical antipsychotics primarily target dopamine receptors, while atypical antipsychotics also affect serotonin receptors.
The pharmaceutical API category of antipsychotics includes various well-known drugs, such as haloperidol, chlorpromazine, risperidone, quetiapine, and olanzapine. These APIs are often formulated into different dosage forms, including tablets, capsules, injections, and oral suspensions, to provide flexibility in administration and patient-specific needs.
Antipsychotics offer relief from psychotic symptoms by stabilizing the imbalanced neurotransmitter activity in the brain. However, they may also have certain side effects, such as sedation, weight gain, extrapyramidal symptoms, and metabolic disturbances. It is essential for healthcare professionals to carefully monitor patients receiving antipsychotic treatment to optimize therapeutic benefits while minimizing adverse effects.
In summary, antipsychotics are a vital category of pharmaceutical APIs used to manage psychiatric disorders by modulating neurotransmitter activity in the brain. Their effectiveness in treating psychosis has made them a cornerstone of mental health treatment, providing much-needed relief to individuals suffering from these conditions.
Valpromide API manufacturers & distributors
Compare qualified Valpromide API suppliers worldwide. We currently have 1 companies offering Valpromide API, with manufacturing taking place in 1 different countries. Use the table below to review supplier type, countries of origin, certifications, product portfolio and GMP audit availability.
| Supplier | Type | Country | Product origin | Certifications | Portfolio |
|---|---|---|---|---|---|
| Sanofi | Producer | France | France | CoA, GMP | 93 products |
When sending a request, specify which Valpromide API quality you need: for example EP (Ph. Eur.), USP, JP, BP, or another pharmacopoeial standard, as well as the required grade (base, salt, micronised, specific purity, etc.).
Use the list above to find high-quality Valpromide API suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our help page to learn more about sourcing APIs via Pharmaoffer.
